nicotine has been researched along with dihydropyridines in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (72.73) | 18.2507 |
2000's | 1 (9.09) | 29.6817 |
2010's | 1 (9.09) | 24.3611 |
2020's | 1 (9.09) | 2.80 |
Authors | Studies |
---|---|
Atkinson, J; Capdeville-Atkinson, C; Chillon, JM; Henrion, D | 1 |
Atkinson, J; Bray-des Boscs, L; Capdeville-Atkinson, C; Chillon, JM; Hoffman, M; Lartaud, I; Makki, T; Nicolas, JP | 1 |
Kumar, A; Schliebs, R | 1 |
García, AG; López, MG; Shukla, R; Wakade, AR | 1 |
Meehan, SM; Schechter, MD | 1 |
Nishikawa, M; Okamura, T; Toda, N | 1 |
Bisenieks, EA; Cebers, G; Duburs, GIa; Germane, SK; Karpova, MN; Klusa, VE; Pankov, OIu | 1 |
Damaj, MI; Dukat, M; Glassco, W; Martin, BR | 1 |
Gerzanich, V; Simard, JM; West, GA; Zhang, F | 1 |
Chen, W; Li, L; Li, Z; Xu, X; Yang, X; Zhai, H; Zhang, W | 1 |
Bansal, N; Khurana, K; Kumar, M | 1 |
11 other study(ies) available for nicotine and dihydropyridines
Article | Year |
---|---|
Effect of chronic treatment with the calcium entry blocker, isradipine, on vascular calcium overload produced by vitamin D3 and nicotine in rats.
Topics: Animals; Aorta, Thoracic; Blood Pressure; Body Weight; Calcium; Calcium Channel Blockers; Cholecalciferol; Dihydropyridines; Endothelium, Vascular; Heart Rate; Isradipine; Male; Mesenteric Arteries; Models, Biological; Muscle Relaxation; Muscle, Smooth, Vascular; Nicotine; Rats; Rats, Inbred Strains; Time Factors | 1992 |
Haemodynamic effects of a new dihydropyridine calcium entry blocker, S-12968-(-), in a rat model of cardiovascular calcium overload.
Topics: Animals; Blood Pressure; Body Weight; Calcium; Calcium Channel Blockers; Cardiac Output; Cholecalciferol; Dihydropyridines; Heart Rate; Hemodynamics; Magnesium; Male; Nicotine; Nifedipine; Nitroprusside; Rats; Stereoisomerism; Vascular Resistance | 1992 |
Postnatal laminar development of cholinergic receptors, protein kinase C and dihydropyridine-sensitive calcium antagonist binding in rat visual cortex. Effect of visual deprivation.
Topics: Age Factors; Animals; Autoradiography; Calcium Channel Blockers; Calcium Channels; Dihydropyridines; Isradipine; Nicotine; Phorbol Esters; Protein Kinase C; Rats; Rats, Wistar; Receptors, Cholinergic; Sensory Deprivation; Vision, Ocular; Visual Cortex | 1992 |
A dihydropyridine-resistant component in the rat adrenal secretory response to splanchnic nerve stimulation.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetylcholine; Adrenal Glands; Animals; Cadmium; Calcium; Calcium Channel Blockers; Calcium Channels; Catecholamines; Dihydropyridines; Drug Resistance; Electric Stimulation; Hexamethonium; Hexamethonium Compounds; Isradipine; Male; Neural Conduction; Nicotine; Potassium; Rats; Receptors, Muscarinic; Receptors, Nicotinic; Splanchnic Nerves | 1992 |
Further evidence for the mechanisms that may mediate nicotine discrimination.
Topics: Animals; Calcium Channel Blockers; Dihydropyridines; Discrimination Learning; Dopamine; Dose-Response Relationship, Drug; Indoles; Isradipine; Male; Nicotine; Rats; Rats, Inbred Strains; Thiazepines; Tropisetron | 1992 |
[Effect of the novel calcium antagonist AE0047 on responses of isolated dog blood vessels to vasoconstricting agents and to nerve stimulation].
Topics: Animals; Blood Vessels; Calcium Channel Blockers; Dihydropyridines; Dogs; Dose-Response Relationship, Drug; Electric Stimulation; Female; In Vitro Techniques; Male; Neurotransmitter Agents; Nicotine; Peripheral Nerves; Vasoconstriction; Vasoconstrictor Agents | 1995 |
[The anticonvulsant properties of glutapyrone--a new type of derivative of amino acid-containing 1,4-dihydropyridines].
Topics: Animals; Anticonvulsants; Arecoline; Calcium; Cerebral Cortex; Dihydropyridines; Drug Evaluation, Preclinical; Epilepsy, Generalized; Glutamates; Male; Mice; Mice, Inbred ICR; Nicotine; Pentylenetetrazole; Rats; Rats, Wistar; Synaptosomes; Tremor | 1993 |
Pharmacological characterization of nicotine-induced seizures in mice.
Topics: Animals; Anticonvulsants; Brain Chemistry; Calcium Signaling; Dihydropyridines; Glutamic Acid; Injections, Intraventricular; Injections, Subcutaneous; Male; Mice; Mice, Inbred ICR; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Nitric Oxide; Receptors, N-Methyl-D-Aspartate; Receptors, Nicotinic; Seizures | 1999 |
Chronic nicotine alters NO signaling of Ca(2+) channels in cerebral arterioles.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Arterioles; Barium; Calcium; Calcium Channels; Calcium Channels, L-Type; Cerebral Arteries; Cerebrovascular Circulation; Cyclic GMP; Dihydropyridines; Electric Stimulation; Female; Membrane Potentials; Muscle, Smooth, Vascular; Nicotine; Nifedipine; Nitric Oxide; Nitroprusside; Potassium Channels; Rats; Rats, Inbred WKY; Signal Transduction; Time Factors; Tyrphostins | 2001 |
Design, multicomponent synthesis, and bioactivities of novel neonicotinoid analogues with 1,4-dihydropyridine scaffold.
Topics: Animals; Aphids; Dihydropyridines; Insecticides; Magnetic Resonance Spectroscopy; Mass Spectrometry; Nicotine | 2010 |
Lacidipine Attenuates Symptoms of Nicotine Withdrawal in Mice.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Brain; Calcium Channel Blockers; Calcium Channels, L-Type; Catalase; Dihydropyridines; Elevated Plus Maze Test; Female; Glutathione; Hindlimb Suspension; Lipid Peroxidation; Male; Mice; Nicotine; Substance Withdrawal Syndrome; Superoxide Dismutase | 2021 |